Navigation Links
AstraZeneca Partners With Primary Health Care to Help Iowa Uninsured
Date:7/16/2009

WILMINGTON, Del., July 16 /PRNewswire-FirstCall/ -- AstraZeneca (NYSE: AZN) announced today that it will provide free medication to eligible patients through Primary Health Care in Des Moines, under one of the company's prescription savings programs.

The AZ&Me(TM) Prescription Savings program for healthcare facilities provides medicines free of charge to community free clinics, community health centers, hospitals and other qualifying facilities that serve patients without prescription drug coverage. This enables patients to quickly get the medicines they need, often at the same place they receive their medical care.

"AstraZeneca believes it is important to help those who need our medicines," said Jennifer McGovern, Director, Patient Assistance Programs, AstraZeneca Pharmaceuticals LP. "We understand that our medicines don't do patients any good if they cannot access them."

In 2008, AstraZeneca provided $8.6 million in savings to more than 5,400 patients in Iowa. Nationally, the company helped more than 440,000 patients save $612 million on their medicines.

Primary Health Care is a nonprofit community health center dedicated to providing healthcare and supportive services for people in Central Iowa to improve their quality of life. In 2008, Primary Health Care served nearly 22,300 patients by providing more than 70,000 medical, dental and mental health visits to residents of Polk and Marshall Counties. Of those served by Primary Health Care, 55 percent are uninsured.

"At Primary Health Care, we believe that everyone is entitled to quality health care regardless of their financial status," said Kelly Huntsman, Executive Director, Primary Health Care. "Through our collaboration with AstraZeneca, we will be able to provide solutions for the uninsured in Iowa, creating accessibility to medications that are critical to their health."

The AZ&Me Prescription Savings program for healthcare facilities is available to non-profit organizations that have a licensed outpatient pharmacy or dispensary on site and meet other program criteria. Patients are eligible for AstraZeneca medicines through this program if they do not have prescription drug coverage and have a household income at or below $30,000 for an individual, or $60,000 for a family of four.

With this program, AstraZeneca builds on its more than 30-year history of helping patients afford the medicines they need.

To learn if your organization qualifies for the AZ&Me Prescription Savings program for healthcare facilities, please call 1-866-325-8198. Program specialists are available Monday through Friday between the hours of 9:00 AM and 5:00 PM ET.

Prescription savings programs are available regardless of which medications your doctors prescribe. To find out more about the more than 475 savings programs covering 2,500 medications, please visit www.pparx.org or call 1-888-4ppa-now (1-888-477-2669).

About AstraZeneca

AstraZeneca is engaged in the research, development, manufacturing and marketing of meaningful prescription medicines and in the supply of healthcare services. AstraZeneca is one of the world's leading pharmaceutical companies with global healthcare sales of $ 31.6 billion and is a leader in gastrointestinal, cardiovascular, neuroscience, respiratory, oncology and infectious disease medicines. In the United States, AstraZeneca is a $13.5 billion dollar healthcare business.

For more information about AstraZeneca in the US or our AZ&Me(TM) Prescription Savings programs, please visit: www.astrazeneca-us.com.

About Primary Health Care, Inc. (PHC)

PHC has been providing medical, dental and support services to the underserved since 1981. PHC offers a full spectrum of medical and dental services, including family practice, adult medicine, pediatrics, OB, mental health, oral medicine, pharmacy, lab and x-ray. Each clinic provides preventive services, such as immunizations and screenings. PHC specializes in caring for the underserved and homeless.

The timeline of steady growth for PHC includes: 1988-Health Care for the Homeless; 1991-Ryan White HIV care; 1998-Maternal Child Programs in partnership with the State of Iowa and later Healthy Start; 2000-Housing Advocacy via HUD (Housing and Urban Development) funding; 2001-new site in Marshalltown; 2002-Relocation from Broadlawns Medical Center to 2353 SE 14th Street; 2003-East Side Clinic; 2004-Community Access Pharmacy; 2005-new dental unit in Marshalltown; 2007-Des Moines dental clinic expansion, and both East Side and South Side service expansions. Our premiere project for 2008-2009 is the relocation of the Outreach Clinic. For more information about PHC, please visit www.phcinc.net


'/>"/>
SOURCE AstraZeneca
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. AstraZeneca and Mental Health Research Institute in Australia Announce Collaboration to Improve Early Detection of Alzheimers Disease
2. Abbott and AstraZeneca Extend Relationship to Include Co-Promotion of TRILIPIX(R) (fenofibric acid)
3. Abbott and AstraZeneca Submit New Drug Application to the FDA for CERTRIAD(TM), an Investigational Treatment for Mixed Dyslipidemia
4. AstraZeneca Studies Show Relief of Nighttime Heartburn and Reduction in GERD-Related Sleep Disturbances
5. Verus Pharmaceuticals Announces a Lawsuit Against AstraZeneca AB and Tika Lakemedel AB
6. Court Grants AstraZeneca Preliminary Injunction Against Apotex in PULMICORT RESPULES Patent Litigation
7. AstraZeneca, the National Alliance for Hispanic Health and LULAC Join Forces to Promote Needed Heart Health Education in Hispanic Communities
8. AstraZeneca Announces TOPROL-XL(R) (Metoprolol Succinate) is Now Available
9. Ingenuity Systems Announces Multi-Year Deal With AstraZeneca
10. Court Grants AstraZeneca Temporary Restraining Order Against Apotex in PULMICORT RESPULES Patent Litigation
11. FDA Advisory Committee Documents for SEROQUEL XR Available on AstraZeneca Web Site
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/28/2017)... ... April 28, 2017 , ... Ushio America ... lamps offer an instant energy-saving solution for F32T8 fluorescent lamps on most instant-start ... ballasts. These 50,000 hour rated lamps utilize the existing electronic ballast, saving labor ...
(Date:4/28/2017)... Manhattan New york (PRWEB) , ... April 28, ... ... is pleased to announce that Aditya Patel M.D. has joined the revolutionary endoscopic ... fellowship training and board certification in Interventional Pain Medicine. The patented, revolutionary eDiscSculpt ...
(Date:4/28/2017)... Edinburg, Texas (PRWEB) , ... April 28, 2017 , ... ... a plaque in recently to the labor and delivery team at Women’s Hospital at ... generous mothers who give birth at the hospital and decide to donate. , ...
(Date:4/28/2017)... ... April 28, 2017 , ... Early detection and elimination ... safety and minimize the cost of development. In this webinar, sponsored by Molecular ... lines and for cardiac toxicity using induced pluripotent stem cells (iPSCs). , In ...
(Date:4/28/2017)... ... 28, 2017 , ... Bill Howe started his sewer and drain company in ... Howe joined the team, the Bill Howe brand was born and they began cultivating ... giving back to the San Diego community in which they worked, lived and were ...
Breaking Medicine News(10 mins):
(Date:4/20/2017)... Texas , April 20, 2017  Vivify Health, ... mobile devices, has been awarded a very significant patent ... via EMRs to continual care via digital health.  This ... key intellectual property and further secures Vivify,s position as ... launched in 2009, was the first company to apply ...
(Date:4/20/2017)... WOONSOCKET, R.I. , April 20, 2017 /PRNewswire/ ... (NYSE: CVS), today unveiled a new store design ... new assortment of healthier food, health-focused products and ... the store to help customers discover new offerings. ... represent the next evolution of the customer experience ...
(Date:4/20/2017)... LUND, Sweden , April 20, 2017 /PRNewswire/ ... OTCQX: NEVPF) ("NeuroVive") today announced positive preclinical ... company,s preclinical compound for non-alcoholic steatohepatitis (NASH), ... NV556 has previously ... STAM™ NASH model. Today, NeuroVive,s scientists present ...
Breaking Medicine Technology: